Nifty
:
16992.55
Sensex
:
57720.37
47.50 (0.28%)
193.27 (0.34%)
Nifty
Sensex
:
:
16992.55
57720.37
47.50 (0.28%)
193.27 (0.34%)

Lyka Labs Ltd.

Pharmaceuticals & Drugs

Rating :
53/99

BSE: 500259 | NSE: LYKALABS

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 317.79
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 430.89
  • N/A
  • 61.01

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 47.59%
  • 3.77%
  • 38.77%
  • FII
  • DII
  • Others
  • 0.37%
  • 4.00%
  • 5.50%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.32
  • 26.54
  • 46.69

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.72
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.26
  • 2.79
  • 5.46

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 97.07
  • 146.57
  • 52.44

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 22
Dec 21
Var%
Sep 22
Sep 21
Var%
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Net Sales
17.82
35.57
-49.90%
25.53
73.89
-65.45%
27.49
49.44
-44.40%
35.19
24.26
45.05%
Expenses
15.60
22.55
-30.82%
20.50
28.26
-27.46%
21.19
19.54
8.44%
22.58
18.02
25.31%
EBITDA
2.21
13.02
-83.03%
5.03
45.63
-88.98%
6.30
29.90
-78.93%
12.60
6.24
101.92%
EBIDTM
12.42%
36.60%
19.70%
61.76%
22.92%
60.48%
35.82%
25.73%
Other Income
1.06
0.41
158.54%
1.19
0.69
72.46%
0.72
0.47
53.19%
0.53
0.55
-3.64%
Interest
3.08
4.64
-33.62%
3.03
5.57
-45.60%
2.91
6.93
-58.01%
2.99
6.37
-53.06%
Depreciation
3.47
2.24
54.91%
3.62
3.52
2.84%
3.59
2.13
68.54%
9.46
2.02
368.32%
PBT
-10.29
6.72
-
-0.64
33.33
-
0.76
21.31
-96.43%
-2.11
-2.65
-
Tax
0.23
0.44
-47.73%
-0.30
5.66
-
0.05
1.83
-97.27%
12.88
-4.22
-
PAT
-10.52
6.28
-
-0.34
27.68
-
0.71
19.48
-96.36%
-14.99
1.57
-
PATM
-59.06%
17.65%
-1.34%
37.45%
2.58%
39.41%
-42.60%
6.48%
EPS
-3.63
2.12
-
-0.13
9.91
-
0.21
6.81
-96.92%
-5.25
0.40
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Mar 13
Net Sales
106.03
194.08
86.25
61.49
70.78
59.81
110.08
130.41
166.27
118.86
127.12
Net Sales Growth
-42.11%
125.02%
40.27%
-13.13%
18.34%
-45.67%
-15.59%
-21.57%
39.89%
-6.50%
 
Cost Of Goods Sold
42.26
52.97
37.97
35.79
39.25
29.38
53.85
70.43
90.74
64.14
66.90
Gross Profit
63.77
141.11
48.28
25.70
31.54
30.43
56.23
59.98
75.53
54.72
60.22
GP Margin
60.15%
72.71%
55.98%
41.80%
44.56%
50.88%
51.08%
45.99%
45.43%
46.04%
47.37%
Total Expenditure
79.87
92.94
66.57
65.16
72.68
63.36
87.31
110.25
137.62
110.32
105.56
Power & Fuel Cost
-
3.92
2.94
2.56
2.28
1.86
1.90
1.39
2.06
3.11
1.91
% Of Sales
-
2.02%
3.41%
4.16%
3.22%
3.11%
1.73%
1.07%
1.24%
2.62%
1.50%
Employee Cost
-
18.06
14.57
13.86
14.69
16.98
17.24
14.71
17.26
16.39
13.80
% Of Sales
-
9.31%
16.89%
22.54%
20.75%
28.39%
15.66%
11.28%
10.38%
13.79%
10.86%
Manufacturing Exp.
-
4.20
3.00
1.73
1.32
1.06
1.20
1.24
1.93
1.46
2.00
% Of Sales
-
2.16%
3.48%
2.81%
1.86%
1.77%
1.09%
0.95%
1.16%
1.23%
1.57%
General & Admin Exp.
-
6.29
4.31
5.70
5.91
5.81
5.96
6.62
7.42
5.90
5.74
% Of Sales
-
3.24%
5.00%
9.27%
8.35%
9.71%
5.41%
5.08%
4.46%
4.96%
4.52%
Selling & Distn. Exp.
-
5.75
2.65
2.27
5.17
2.95
0.37
8.61
13.20
11.03
8.85
% Of Sales
-
2.96%
3.07%
3.69%
7.30%
4.93%
0.34%
6.60%
7.94%
9.28%
6.96%
Miscellaneous Exp.
-
1.74
1.14
3.24
4.07
5.31
6.80
7.25
5.00
8.29
8.85
% Of Sales
-
0.90%
1.32%
5.27%
5.75%
8.88%
6.18%
5.56%
3.01%
6.97%
5.00%
EBITDA
26.14
101.14
19.68
-3.67
-1.90
-3.55
22.77
20.16
28.65
8.54
21.56
EBITDA Margin
24.65%
52.11%
22.82%
-5.97%
-2.68%
-5.94%
20.68%
15.46%
17.23%
7.18%
16.96%
Other Income
3.50
2.09
1.56
3.09
2.09
2.13
2.24
2.06
2.35
5.37
3.35
Interest
12.01
20.13
25.94
20.07
7.17
9.58
18.72
16.42
25.57
28.53
20.78
Depreciation
20.14
17.35
8.32
8.01
7.31
11.28
10.25
9.32
10.87
8.80
11.70
PBT
-12.28
65.77
-13.02
-28.66
-14.29
-22.28
-3.97
-3.52
-5.44
-23.43
-7.56
Tax
12.86
20.80
-4.05
0.74
-9.07
-1.04
-1.51
-0.19
1.06
1.25
0.00
Tax Rate
-104.72%
35.11%
28.62%
-1.20%
58.78%
5.19%
18.62%
-4.86%
-28.96%
-30.79%
0.00%
PAT
-25.14
39.00
-11.55
-60.54
-5.55
-17.21
-5.54
3.69
-4.95
-6.59
-0.71
PAT before Minority Interest
-25.26
38.44
-10.09
-62.62
-6.35
-19.00
-6.60
4.09
-4.72
-5.30
0.41
Minority Interest
-0.12
0.56
-1.46
2.08
0.80
1.79
1.06
-0.40
-0.23
-1.29
-1.12
PAT Margin
-23.71%
20.09%
-13.39%
-98.46%
-7.84%
-28.77%
-5.03%
2.83%
-2.98%
-5.54%
-0.56%
PAT Growth
-145.70%
-
-
-
-
-
-
-
-
-
 
EPS
-8.76
13.59
-4.02
-21.09
-1.93
-6.00
-1.93
1.29
-1.72
-2.30
-0.25

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Mar 13
Shareholder's Funds
13.34
-25.80
-14.34
43.02
49.47
37.71
45.24
43.06
52.71
66.95
Share Capital
28.69
28.69
28.69
28.14
28.14
22.04
23.13
22.67
22.67
22.67
Total Reserves
-15.35
-54.49
-43.03
14.12
20.57
15.67
22.11
20.07
30.05
44.29
Non-Current Liabilities
72.77
148.88
136.67
72.28
5.28
38.68
28.52
36.95
65.16
71.93
Secured Loans
0.86
150.65
125.45
78.39
4.06
34.93
25.31
28.92
50.33
53.58
Unsecured Loans
61.63
0.71
0.64
0.90
0.87
0.84
0.00
0.00
7.67
13.65
Long Term Provisions
3.47
3.66
3.86
4.08
3.63
4.39
2.92
4.30
4.20
3.85
Current Liabilities
99.35
49.88
66.32
84.81
167.12
165.45
162.83
195.24
208.09
147.21
Trade Payables
12.00
14.71
18.85
23.23
24.21
39.16
42.08
54.64
63.26
43.31
Other Current Liabilities
66.25
23.10
30.83
43.31
92.38
73.07
56.55
79.41
77.72
44.17
Short Term Borrowings
20.07
10.37
14.41
16.26
45.82
50.23
59.95
59.85
66.20
58.78
Short Term Provisions
1.05
1.70
2.23
2.02
4.72
2.99
4.26
1.35
0.91
0.96
Total Liabilities
185.61
173.66
187.88
202.85
225.23
248.87
240.50
278.76
329.26
288.90
Net Block
93.96
98.19
104.78
107.73
116.04
132.90
104.23
121.64
162.45
124.69
Gross Block
169.37
202.50
188.36
202.81
155.31
144.01
200.41
213.51
248.18
195.12
Accumulated Depreciation
75.41
104.31
83.58
95.08
39.27
11.11
96.18
91.87
85.73
70.43
Non Current Assets
133.42
144.59
152.00
167.75
176.16
186.07
158.70
177.08
211.17
162.24
Capital Work in Progress
17.74
25.76
27.76
31.07
27.88
24.23
30.17
27.03
21.78
15.38
Non Current Investment
0.01
0.01
0.01
0.01
0.23
0.26
0.39
0.32
0.30
5.53
Long Term Loans & Adv.
21.71
20.63
19.46
28.94
32.01
28.69
23.92
28.09
26.65
16.64
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
52.20
29.08
35.88
35.11
49.07
62.79
81.81
101.69
118.09
126.66
Current Investments
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
8.20
4.31
6.73
7.00
11.20
13.24
10.81
19.25
15.83
18.07
Sundry Debtors
18.45
8.67
8.04
14.63
20.50
29.17
43.29
56.70
68.02
73.40
Cash & Bank
17.05
7.15
10.30
1.71
2.43
5.12
5.56
6.51
10.71
4.80
Other Current Assets
8.49
4.73
6.54
2.13
14.95
15.25
22.14
19.23
23.54
30.38
Short Term Loans & Adv.
5.62
4.21
4.26
9.64
13.21
10.92
17.22
14.57
18.24
16.56
Net Current Assets
-47.15
-20.80
-30.44
-49.70
-118.05
-102.66
-81.03
-93.55
-90.00
-20.55
Total Assets
185.62
173.67
187.88
202.86
225.23
248.86
240.51
278.77
329.26
288.90

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Mar 13
Cash From Operating Activity
79.25
8.81
5.32
26.67
10.88
31.38
11.95
26.54
89.10
10.94
PBT
59.25
-14.14
-61.88
-15.42
-20.04
-8.10
3.69
-4.95
-6.59
-0.71
Adjustment
41.93
35.40
55.76
15.17
20.79
30.53
16.15
31.64
32.87
17.41
Changes in Working Capital
-21.01
-11.64
10.94
27.65
10.36
10.10
-7.57
-0.79
66.90
-5.46
Cash after chg. in Working capital
80.16
9.62
4.82
27.39
11.10
32.53
12.27
25.90
93.17
11.24
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-0.92
-0.81
0.50
-1.10
-0.44
-1.20
-0.33
-0.10
1.02
-0.42
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.12
Extra & Other Items
0.00
0.00
0.00
0.37
0.23
0.06
0.00
0.74
-5.10
0.00
Cash From Investing Activity
-6.17
-0.16
-0.11
-3.97
-3.17
-12.67
17.29
28.99
-56.87
4.54
Net Fixed Assets
-2.28
-20.42
-43.81
-2.41
-3.63
12.94
-4.69
29.40
-9.46
-11.12
Net Investments
0.00
0.00
30.05
-0.01
0.00
0.12
0.00
-0.04
-42.31
0.00
Others
-3.89
20.26
13.65
-1.55
0.46
-25.73
21.98
-0.37
-5.10
15.66
Cash from Financing Activity
-63.18
-11.80
3.38
-23.42
-10.41
-19.15
-30.19
-59.72
-26.32
-12.52
Net Cash Inflow / Outflow
9.90
-3.15
8.60
-0.72
-2.69
-0.43
-0.96
-4.20
5.91
2.97
Opening Cash & Equivalents
7.15
10.30
1.71
2.43
5.12
5.56
6.51
10.71
4.80
1.83
Closing Cash & Equivalent
17.05
7.15
10.30
1.70
2.43
5.12
5.56
6.51
10.71
4.80

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Mar 13
Book Value (Rs.)
4.65
-8.99
-5.00
15.02
16.78
15.82
16.94
14.99
18.55
25.87
ROA
21.40%
-5.58%
-32.05%
-2.97%
-8.02%
-2.70%
1.58%
-1.55%
-1.72%
0.14%
ROE
0.00%
0.00%
-448.65%
-14.20%
-46.30%
-18.27%
11.74%
-13.05%
-11.06%
0.73%
ROCE
56.68%
8.95%
-31.39%
-5.50%
-6.52%
6.66%
12.41%
11.73%
11.93%
10.68%
Fixed Asset Turnover
1.04
0.44
0.31
0.40
0.41
0.68
0.65
0.75
0.57
0.70
Receivable days
25.51
35.37
67.29
90.56
149.54
113.31
136.29
132.10
204.83
183.49
Inventory Days
11.76
23.36
40.77
46.92
73.58
37.61
40.97
37.15
49.11
46.62
Payable days
92.01
161.35
117.58
127.84
181.43
174.53
168.94
158.77
188.04
138.63
Cash Conversion Cycle
-54.74
-102.62
-9.53
9.65
41.69
-23.60
8.32
10.48
65.90
91.48
Total Debt/Equity
9.76
-6.30
-9.85
2.28
2.39
3.60
3.12
4.05
3.97
2.62
Interest Cover
3.94
0.45
-2.08
-1.15
-1.09
0.57
1.24
0.86
0.86
1.02

Annual Reports:

FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013

News Update:


  • Lyka Labs - Quarterly Results
    7th Feb 2023, 14:01 PM

    Read More
  • Lyka Labs signs agreement with Agilis Healthcare to acquire animal healthcare business
    21st Dec 2022, 17:13 PM

    The cost of acquisition is up to Rs 3.5 crore

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.